Podrobno

Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data
ID Teixeira, Pedro F. (Avtor), ID Battelino, Tadej (Avtor), et al.

.pdfPDF - Predstavitvena datoteka, prenos (688,67 KB)
MD5: F41BE38AF0D5267AB9F74CE3A2BA7FFA
URLURL - Izvorni URL, za dostop obiščite https://link.springer.com/article/10.1007/s00125-024-06089-5 Povezava se odpre v novem oknu

Izvleček
The type 1 diabetes community is coalescing around the benefits and advantages of early screening for disease risk. To be accepted by healthcare providers, regulatory authorities and payers, screening programmes need to show that the testing variables allow accurate risk prediction and that individualised risk-informed monitoring plans are established, as well as operational feasibility, cost-effectiveness and acceptance at population level. Artificial intelligence (AI) has the potential to contribute to solving these issues, starting with the identification and stratification of at-risk individuals. ASSET (AI for Sustainable Prevention of Autoimmunity in the Society; www.asset.healthcare) is a public/private consortium that was established to contribute to research around screening for type 1 diabetes and particularly to how AI can drive the implementation of a precision medicine approach to disease prevention. ASSET will additionally focus on issues pertaining to operational implementation of screening. The authors of this article, researchers and clinicians active in the field of type 1 diabetes, met in an open forum to independently debate key issues around screening for type 1 diabetes and to advise ASSET. The potential use of AI in the analysis of longitudinal data from observational cohort studies to inform the design of improved, more individualised screening programmes was also discussed. A key issue was whether AI would allow the research community and industry to capitalise on large publicly available data repositories to design screening programmes that allow the early detection of individuals at high risk and enable clinical evaluation of preventive therapies. Overall, AI has the potential to revolutionise type 1 diabetes screening, in particular to help identify individuals who are at increased risk of disease and aid in the design of appropriate follow-up plans. We hope that this initiative will stimulate further research on this very timely topic.

Jezik:Angleški jezik
Ključne besede:AI, artificial intelligence, ASSET, children, precision medicine, prevention, screening, type 1 diabetes
Vrsta gradiva:Članek v reviji
Tipologija:1.03 - Drugi znanstveni članki
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:Str. 985–994
Številčenje:Vol. 67, iss. 6
PID:20.500.12556/RUL-182887 Povezava se odpre v novem oknu
UDK:616.379
ISSN pri članku:1432-0428
DOI:10.1007/s00125-024-06089-5 Povezava se odpre v novem oknu
COBISS.SI-ID:185855491 Povezava se odpre v novem oknu
Datum objave v RUL:27.05.2026
Število ogledov:287
Število prenosov:184
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Diabetologia
Skrajšan naslov:Diabetologia
Založnik:Springer Nature
ISSN:1432-0428
COBISS.SI-ID:512012825 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:umetna inteligenca, ASSET, otroci, precizna medicina, preprečevanje, presejanje, sladkorna bolezen tipa 1

Projekti

Financer:VINNOVA - Swedish Innovation Agency
Številka projekta:2021-02684

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj